Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PLD3 |
| Upstream (Parents) |
|---|
| (<<) BCL2L1 → PLD3 |
| (<<) CFL1 → PLD3 |
| (<<) CYB5R3 → PLD3 |
| (<<) DAZAP2 → PLD3 |
| (<<) JUND → PLD3 |
| (<<) RPS16 → PLD3 |
| Downstream (Children) |
|---|
| PLD3 → ACTN4 (>>) |
| PLD3 → ADRBK1 (>>) |
| PLD3 → AKT2 (>>) |
| PLD3 → CD4 (>>) |
| PLD3 → CRTC1 (>>) |
| PLD3 → CXCL1 (>>) |
| PLD3 → DNM1L (>>) |
| PLD3 → EEF1E1 (>>) |
| PLD3 → EFHD2 (>>) |
| PLD3 → FDPS (>>) |
| PLD3 → FLJ35390 (>>) |
| PLD3 → GALK1 (>>) |
| PLD3 → GNA13 (>>) |
| PLD3 → GNAI2 (>>) |
| PLD3 → GRN (>>) |
| PLD3 → HGS (>>) |
| PLD3 → HLA-G (>>) |
| PLD3 → ITGB4 (>>) |
| PLD3 → KLK3 (>>) |
| PLD3 → KREMEN2 (>>) |
| PLD3 → KRT34 (>>) |
| PLD3 → LRCH4 (>>) |
| PLD3 → MAL (>>) |
| PLD3 → MAP2K2 (>>) |
| PLD3 → MAP3K10 (>>) |
| PLD3 → MAPK3 (>>) |
| PLD3 → NRSN2 (>>) |
| PLD3 → OGFR (>>) |
| PLD3 → PAK4 (>>) |
| PLD3 → PDK2 (>>) |
| PLD3 → PIP5K1C (>>) |
| PLD3 → PKM2 (>>) |
| PLD3 → POU3F3 (>>) |
| PLD3 → PRKCD (>>) |
| PLD3 → PTMA (>>) |
| PLD3 → RAB5C (>>) |
| PLD3 → RAC2 (>>) |
| PLD3 → RASD1 (>>) |
| PLD3 → RAVER1 (>>) |
| PLD3 → RELL2 (>>) |
| PLD3 → RHOT2 (>>) |
| PLD3 → RNF5 (>>) |
| PLD3 → RPS6KA4 (>>) |
| PLD3 → RRP15 (>>) |
| PLD3 → SF3A2 (>>) |
| PLD3 → SH3GL1 (>>) |
| PLD3 → SH3GLB2 (>>) |
| PLD3 → SHC2 (>>) |
| PLD3 → SMURF2 (>>) |
| PLD3 → ST3GAL2 (>>) |
| PLD3 → TGFB1 (>>) |
| PLD3 → TMEM88 (>>) |
| PLD3 → TPP1 (>>) |
| PLD3 → UBE2D2 (>>) |
| PLD3 → VAC14 (>>) |
| PLD3 → ZFP36 (>>) |
| PLD3 → ZFPM1 (>>) |
| PLD3 → ZNF579 (>>) |
